Weight-loss drug developer Metsera raises $290 million in funding
Metsera, a pioneering pharmaceutical company specializing in weight-loss drugs, has recently made headlines in the healthcare industry with its remarkable achievement of securing a whopping $290 million in funding. This significant capital infusion marks a pivotal moment for the company as it embarks on its mission to combat the global epidemic of obesity. Founded in … Read more